Search
【報告用大圖：🙋🏼首次癲癇發作處理流程圖 (新)】
👉🏻👉🏻👉🏻精選輯蓄勢待發中🙏🏻
#與上課學得不一樣喔 #用流程圖學比較快
http://jerryljw.blogspot.tw/…/treatment-algorithm-of-new-on…
Partnering with GLORIA of MOST, InnoVEX Forum will focus on #Biotech in the afternoon session at on May 29, 15:45-16:30. Titled “AI and Biomedical Innovations are Transforming Healthcare,” Doctors and Professors from NTU are invited to share their views on AI applications in Biotech and medical services. Featured speakers of the session include:
Professor Pan-Chyr Yang, Chair Professor of the Department of Internal Medicine, College of Medicine and Former President of National Taiwan University. His research group successfully established new platforms of theranostic applications of aptamer, lung cancer stem cell and tumor microenvironment directed therapy that may be beneficial and improve treatment of lung cancer patients.
Professor Feipei Lai, secretary in medical affairs, National Taiwan University Hospital. He was a vice superintendent of National Taiwan University Hospital. He was the chairman of Taiwan Network Information Center. His current research interest is Medical Informatics.
Professor Chien-Yu, Chen, Department of Bio-Industrial Mechatronics Engineering, National Taiwan University. She has expertise in Bioinformatics, machine learning, and gene regulatory networks. She mainly focuses on designing machine learning methods for solving problems of molecular biology.
Professor Paul Hwu, Department of Pediatrics at the National Taiwan University Hospital (NTUH) in Taiwan. He set up the Newborn Screening Program for Pompe Disease in Taiwan, one of the first in the world, and has dedicated much of his research and clinical effort in the diagnosis, management, and gene therapy for patients with rare genetic diseases.
Bor-Sheng (Kevin) Ko is currently an attending physician and Assistant Professor at National Taiwan University Hospital, the president of Taiwan Society of Blood and Marrow Transplant, and the president of Taiwan Society of Pharmacoeconomics and Outcome Research. He is the co-founder for the NTUH IRB approved AHEAD project and responsible for clinical validation for the algorithm and development for related clinical application.
More information on the InnoVEX Forum and more speakers will be introduced on our social media and website.
Follow us for the most up-to-date information!
The #InnoVEXForum lasts for the entire #InnoVEX2019: May 29 - 31.
Visit our website for the full program agenda:
https://innovex.computex.biz/2019/SHOW/programAgenda.aspx
Save your seat in the InnoVEX Forum here:
https://www.accupass.com/event/1904100716101915130969
敗血性休克使用輸液急救的指引，很好用，一目瞭然。
PS：除了文謅謅的論文寫作之外，這種圖表式的流程圖最能表達理念及作法指引。
任何一篇實務性的長篇大論，若是無法以這種流程圖(Algorithm)來表達作者理念，就是有兩種原因，第一，作者本身還沒完全搞清楚他在寫些什麼；第二，就是這篇文章跟本沒有健全結構，無法呈現Algorithmm。
PS again, 有時候學生學習不佳，考試成績差，實務應用差，授課老師也是有責任的。
A users’ guide to the 2016 Surviving Sepsis Guidelines
Two aspects of the guidelines should be understood. We illuminate these two aspects through an analysis of the priority currently assigned to early identification and initial treatment of sepsis, including antibiotics and fluid therapy.
First, the recommendation for antibiotic administration within an hour of diagnosis of sepsis is a lofty goal of care, judged to be ideal for the patient but not yet standard care. Despite the best intentions of the healthcare team, antibiotic administration within 1 h from time of diagnosis may be difficult due to the complexity of the hospital environment and essential care being delivered to other patients during the same time period by the same healthcare practitioners and health system. This is one among several “aspirational recommendations” considered by the experts to represent best practice that individual practitioners and healthcare teams should strive to operationalize.
Second, the clinician may push back from use of recommendations for fear that evidence-based guidelines lead to “cookie cutter” medicine and reflexive behaviors that deemphasize the “art” of medicine. The recommendations are intended for a “typical” septic patient. Patients still benefit from the art of medicine, which includes interpretation of data and individualization of treatment. The recommendations provide much-needed general treatment guidance to the bedside decision maker who is busy, pressured to see more patients in less time, and who will use a distillation of the current literature into a coherent set of recommendations suitable for the large majority of septic patients who are “typical”. For most of us in the trenches of everyday care, the lists of specific recommendations (seen in the tables in the manuscript) are a welcome adjunct to personalizing care.
This guidance includes sepsis management in the emergency department, the general hospital floors, and the ICU. For example, the recommendation for an initial 30 mL/kg crystalloid infusion for tissue hypoperfusion is chosen as a one value fit for bedside guidance. Administering 30 mL/kg crystalloid is a useful initial therapy for the majority of patients and this literature supported fluid dose is linked to good outcomes [3, 4]. Figure 2 offers guidance for initial fluid resuscitation and is built forward from the guidelines recommendation for 30 mL/kg initial crystalloid fluid administration within the first six hours for sepsis-induced tissue hypoperfusion. The flow diagram incorporates some of our own opinions for successful fluid resuscitation based on experience and our understanding of the literature.
http://rdcu.be/oGqJ
Guidelines and algorithms ... algorithm for patients with Type 2 diabetes that is consistent ... Adherence to the treatment algorithm is monitored. ... <看更多>
treatment algorithm 在 Treatment Algorithm in Covid--19 - YouTube 的八卦
Treatment Algorithm in Covid--19. 103,693 views • May 3, 2021 • Update on Current medical management of Covid-19 … Show more. Show more. ... <看更多>